TherapeuticsMD, Inc. (29TA)
Munich
Closed
Aug 31, 2026
Day's Range
1.8952 wk Range
0.9000Overview - 29TA - TherapeuticsMD, Inc.
Key Statistics
Valuation
Enterprise Value
-1.38M
P/E (Trailing)
‪-37.79‬
PEG Ratio
‪0.32‬
Price / Book
‪0.81‬
EV / EBITDA
‪0.48‬
Profitability
Operating Margin
‪-139.44%‬
Return on Assets
‪-1.51%‬
Return on Equity
‪-2.11%‬
Ownership
Shares Outstanding
11.57M
Price stats
50-Day Avg
‪1.79‬
200-Day Avg
‪1.77‬
Peers - 29TA - TherapeuticsMD, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Munich.
- 29TAMunichTherapeuticsMD, Inc.+49.73%52-week change-37.80P/E (Trailing)—Profit Margin
- 3KFMunichAuxly Cannabis Group Inc.+94.35%52-week change4.53P/E (Trailing)‪57.26%‬Profit Margin
- HLSMunichAIC Mines Limited+64.23%52-week change—P/E (Trailing)—Profit Margin
- PA8MunichPaion AG+81.23%52-week change-0.81P/E (Trailing)‪94.10%‬Profit Margin
- I76MunichIronwood Pharmaceuticals Inc.+69.73%52-week change24.67P/E (Trailing)—Profit Margin
- 6CWMunichCharlottes Web Holdings Inc.+69.64%52-week change-1.47P/E (Trailing)‪43.48%‬Profit Margin
- E7PMunichIndivior Pharmaceuticals, Inc.+62.36%52-week change21.19P/E (Trailing)‪80.14%‬Profit Margin
Profile Summary - 29TA - TherapeuticsMD, Inc.
About
TherapeuticsMD, Inc. is a pharmaceutical royalty company focused on women’s health. TherapeuticsMD licenses and commercializes prescription products used in menopause management, contraception, and reproductive health, including BIJUVA, IMVEXXY, and ANNOVERA, through its licensing partners. The company also offers…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
